Vetoquinol - Universal Registration Document - 2021

CONSOLIDATED FINANCIAL STATEMENTS Notes to the consolidated financial statements Vetoquinol Universal Registration Document 2020 Financial report 77 6 6.5.8.2 2019 operating segment results €000 By asset location Europe Americas Asia/Pacific (rest of world) Consolidated total Sales 347,561 161,430 40,795 549,787 Inter-segment sales (107,240) (15,006) (73) (122,320) Total external sales 240,321 146,424 40,722 427,467 EBIT 36,027 14,342 5,794 56,164 Non-recurring operating income and expenses (3,315) (15,754) (0) (19,069) Operating income 32,712 (1,412) 5,794 37,095 Net financial income/(expense) (1,516) (205) Income before tax 35,578 40,681 Income tax (16,635) (12,464) Income after tax 18,944 28,217 Earnings/(loss) of associates 286 30 CONSOLIDATED NET INCOME 19,229 Tracking by destination region or end market (per region). €000 By geographical region Europe Americas Asia/Pacific (rest of world) Consolidated total Sales 293,626 172,392 83,768 549,787 Inter-segment sales (82,838) (28,196) (11,286) (122,320) TOTAL EXTERNAL SALES 210,789 144,196 72,482 427,467 The Group also tracks sales by species. €000 By species Pets Food-producing animals Consolidated total Sales 341,796 207,991 549,787 Inter-segment sales (85,077) (37,242) (122,320) TOTAL EXTERNAL SALES 256,719 170,748 427,467